http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ZA-201304579-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8281ac9f4fb11f15a5da018344453338
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P-
filingDate 2013-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1833ffb048ea13a20d1470c4912726e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58e0700e1a508d80eb4b9b94af9e549b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e8a3f3873f5921eb9f57df16e0757df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7e857352958161ca1cbda8ea3653ff1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14b3334fd144136d6a06404474f0a814
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51bcacd432185c8c9027d51c84047663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17ab6e84ea973bf2d467f4c4f692e088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2731c125ba0c82cae282185c094cb457
publicationDate 2014-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ZA-201304579-B
titleOfInvention Phenanthridine macrocyclic hepatitis c serine protesea inhibitors
priorityDate 2010-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71077
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483812
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9189
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406936270

Total number of triples: 25.